NEW YORK (GenomeWeb) – Veracyte today announced that it has signed a research collaboration agreement with GE to develop new diagnostic approaches based on GE Healthcare's digital imaging technology.

The partners will "explore the concept of deriving innovative diagnostic approaches from a combination of digital imaging and genomic technologies," Veracyte CEO Bonnie Anderson said in a statement.

The firms will look to identify features from raw imaging data that, when combined with genomic information, have the potential to inform disease diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.